The difference is not big enough to justify stopping the study.

FORBES: BioSante's Pollyannish Press Release

Two other doctors who discussed Yancy's presentation questioned whether the study was big enough to really allay safety worries.

FORBES: Magazine Article

Which brings me to the second big problem: Monsanto has not been open enough in finding ways to let researchers study its genetic traits or invent new ones.

FORBES: C'mon, Forbes Wasn't Entirely Wrong About Monsanto

But the results were not good enough for Dendreon to file with the Food and Drug Administration, and they could stoke investor fears that the study might not be big enough to prove Provenge is effective--even if the drug really does save lives.

FORBES: Magazine Article